首页> 外文期刊>International Journal of Cardiology >Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP
【24h】

Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP

机译:长期随访在射血分数降低的心力衰竭患者中长期使用血清高敏感性肌钙蛋白T,半乳糖凝集素3和I型胶原蛋白的C末端前肽的水平:与可溶性AXL和BNP的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Prognostic biomarkers are needed to improve the management of the heart failure (HF) epidemic, being the brain natriuretic peptides the most valuable. Here we evaluate 3 biomarkers, high sensitivity troponin T (hs-TnT), galectin-3 (Gal-3) and C-terminal propeptide of type I procollagen (CICP), compare them with a recently described new candidate (sAXL), and analyze their relationship with BNP.
机译:背景:预后生物标志物是改善心力衰竭(HF)流行病的管理所必需的,因为脑钠肽是最有价值的肽。在这里,我们评估了3种生物标记物,即高敏感性肌钙蛋白T(hs-TnT),半乳凝素3(Gal-3)和I型胶原蛋白C(CICP)的C末端前肽,并将它们与最近描述的新候选物(sAXL)进行了比较,并且分析他们与法国巴黎银行的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号